Allscripts Healthcare Solutions, Inc. Expected to Earn Q2 2021 Earnings of $0.11 Per Share (NASDAQ:MDRX)

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) – Equities researchers at Colliers Securities issued their Q2 2021 earnings per share estimates for shares of Allscripts Healthcare Solutions in a note issued to investors on Monday, May 3rd. Colliers Securities analyst G. Mannheimer anticipates that the software maker will earn $0.11 per share for the quarter.

MDRX has been the topic of a number of other reports. Argus reaffirmed a “hold” rating on shares of Allscripts Healthcare Solutions in a research report on Monday, March 8th. JPMorgan Chase & Co. began coverage on shares of Allscripts Healthcare Solutions in a report on Thursday, April 29th. They set an “underweight” rating on the stock. Piper Sandler cut their price target on Allscripts Healthcare Solutions from $17.00 to $15.00 and set a “neutral” rating for the company in a research note on Friday, February 26th. SVB Leerink increased their price objective on Allscripts Healthcare Solutions from $15.00 to $16.00 and gave the stock a “market perform” rating in a research note on Friday, April 30th. Finally, Canaccord Genuity raised their target price on Allscripts Healthcare Solutions from $17.00 to $18.00 and gave the company a “buy” rating in a report on Friday, April 30th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $12.00.

Shares of Allscripts Healthcare Solutions stock opened at $15.80 on Tuesday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.27 and a quick ratio of 1.27. Allscripts Healthcare Solutions has a one year low of $5.28 and a one year high of $17.96. The business has a 50-day simple moving average of $15.57 and a 200 day simple moving average of $14.74. The firm has a market capitalization of $2.22 billion, a price-to-earnings ratio of -52.67, a PEG ratio of 4.67 and a beta of 1.18.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its earnings results on Wednesday, April 28th. The software maker reported $0.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a negative net margin of 2.77% and a positive return on equity of 5.80%. During the same quarter last year, the firm earned $0.09 EPS.

In other Allscripts Healthcare Solutions news, CEO Paul Black sold 60,000 shares of the firm’s stock in a transaction dated Monday, March 15th. The shares were sold at an average price of $15.72, for a total value of $943,200.00. Also, insider Lisa Khorey sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Thursday, February 18th. The shares were sold at an average price of $16.75, for a total value of $251,250.00. Insiders own 1.42% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. The Manufacturers Life Insurance Company raised its stake in Allscripts Healthcare Solutions by 1.4% during the fourth quarter. The Manufacturers Life Insurance Company now owns 94,629 shares of the software maker’s stock valued at $1,366,000 after buying an additional 1,316 shares during the last quarter. Teachers Retirement System of The State of Kentucky boosted its stake in Allscripts Healthcare Solutions by 5.5% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 29,476 shares of the software maker’s stock worth $240,000 after purchasing an additional 1,530 shares in the last quarter. UBS Asset Management Americas Inc. boosted its stake in Allscripts Healthcare Solutions by 1.3% in the 4th quarter. UBS Asset Management Americas Inc. now owns 209,384 shares of the software maker’s stock worth $3,024,000 after purchasing an additional 2,766 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Allscripts Healthcare Solutions by 15.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,372 shares of the software maker’s stock valued at $337,000 after purchasing an additional 3,065 shares during the last quarter. Finally, Vantage Consulting Group Inc bought a new stake in Allscripts Healthcare Solutions during the 4th quarter valued at about $44,000.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Article: Momentum Investing

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.